ITP: novel treatments
38:40
Bispecific antibodies in lymphoma: an update
48:18
Thalassemia: an update from ASH 2024
54:16
Post #ASH24 Webinar Dedicated to AML
44:54
Integrating Cardio-Oncology Practices into the Treatment of Hematologic Malignancies
40:23
Applying and Selecting the Right Position after Hematology/Oncology Fellowship
49:11
MRD in Acute Lymphoblastic Leukemia: Where do we Stand
42:29
Impact of prior treatment on selinexor bortezomib dexamethasone outcomes in patients with relapse mm
1:10:53